| Efficacy of Dialectical Behavior Therapy Versus CAMS-informed Supportive Psychotherapy on Self Harming Behavior (NCT01512602) | Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital | 2012-01-01 |
| Mindfulness and Interpersonal Effectiveness Skills in Borderline Personality Disorder (NCT02397031) | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 2011-09-01 |
| Event Related Potentials in Borderline Personality Disorder and Major Depression (NCT01469663) | State University of New York - Upstate Medical University | 2011-07-01 |
| Peer Support for Severe Mental Disorders (NCT02276469) | Universitätsklinikum Hamburg-Eppendorf | 2011-07-01 |
| Creativity Group for Borderline Personality Disorder (NCT01343550) | State University of New York - Upstate Medical University | 2011-02-01 |
| "The Effects of Oxytocin on Patients With Borderline Personality Disorder" (NCT01243658) | Prof. Dr. Markus Heinrichs | 2011-01-01 |
| Brief Admission by Self-referral for Individuals With Self-harm: Effects on Compulsory Care (NCT06406972) | Region Skane | 2010-09-15 |
| Preliminary Trial of the Effect of Glucocorticoid Receptor Antagonist on Borderline Personality Disorder (BPD) (NCT01212588) | Indiana University | 2010-09-01 |
| 20 Weeks DBT Group Skills Training Study (NCT01193205) | Centre for Addiction and Mental Health | 2010-07-01 |
| Effects of Motive-Oriented Therapeutic Relationship in the Early-Phase Treatment of Borderline Personality Disorder (NCT01896024) | University of Lausanne Hospitals | 2010-06-01 |
| Safety and Efficacy Study of Citalopram and Lithium for the Treatment of Depressive Mood Disorder Symptoms (NCT01189812) | Columbia Northwest Pharmaceuticals | 2010-03-01 |
| Calling for Care: Cell Phones for Mood Telemetry in Teens (NCT01083823) | Sunnybrook Health Sciences Centre | 2010-03-01 |
| Dialectical Behavior Therapy Rutgers University Research Program (NCT03123198) | Rutgers, The State University of New Jersey | 2010-03-01 |
| Effects of Psychiatric Admissions on Self-harm and Suicide in People With Borderline Personality Disorder (NCT06424509) | Lund University | 2010-01-01 |
| Transcranial Magnetic Stimulation for Borderline Personality Disorder (NCT01076933) | University Hospital, Toulouse | 2010-01-01 |
| Treating PTSD in Patients With Borderline Personality Disorder (NCT01081314) | University of Washington | 2009-08-01 |
| Comparing Treatments for Self-Injury and Suicidal Behavior in People With Borderline Personality Disorder (NCT00834834) | New York State Psychiatric Institute | 2009-03-01 |
| Efficacy of Omega-3 Fatty Acids on Borderline Personality Disorder (NCT00437099) | Hospital Universitari Vall d'Hebron Research Institute | 2009-02-01 |
| Effectiveness of a 24 Hour Phone Line on the Rate of Suicide Attempts in Borderline Patients (NCT00603421) | Assistance Publique - Hôpitaux de Paris | 2009-02-01 |
| Use of Care Services by Patients With Borderline Personality Disorder (NCT02829658) | University Hospital, Toulouse | 2009-02-01 |
| Seroquel Extended Release (XR) for the Management of Borderline Personality Disorder (BPD) (NCT00880919) | University of Minnesota | 2008-06-01 |
| N-Acetylcysteine in Adjunct to DBT for the Treatment of Self-Injurious Behavior in BPD (NCT00539188) | Yale University | 2007-09-01 |
| Topiramate for Treatment of Patients With Borderline Personality Disorder and Alcohol Dependence (NCT00463775) | Elizabeth Ralevski | 2007-03-01 |
| Outcomes of Mentalization-Based Treatment for Borderline Personality Disorder (NCT03295838) | Karolinska Institutet | 2007-02-01 |
| Treatment of Aggression, Anger and Emotional Dysregulation in Borderline Personality Disorder (NCT00467038) | US Department of Veterans Affairs | 2006-11-01 |
| Guanfacine to Treat Borderline Personality Disorder (NCT00358969) | Icahn School of Medicine at Mount Sinai | 2006-07-01 |
| PET Imaging and Olanzapine Treatment in Borderline Personality Disorder (NCT00275301) | University of Minnesota | 2005-12-01 |
| Naltrexone in Borderline Personality Disorder (NCT00124839) | Central Institute of Mental Health, Mannheim | 2005-10-01 |
| Quetiapine Treatment for Symptoms Associated With Borderline Personality Disorder (NCT00122070) | University of Medicine and Dentistry of New Jersey | 2005-05-01 |
| MRI Imaging in Borderline Personality Disorder (NCT00275288) | University of Minnesota | 2005-01-01 |
| Efficacy of Transference-Focused Psychotherapy for Borderline Personality Disorder (NCT00714311) | University Hospital Muenster | 2004-10-01 |
| Evaluation of DBT Compared to Drug Counseling for Opiate Addicts (NCT00117741) | University of Washington | 2004-06-01 |
| Psychodynamic Therapy For Co-occurring Borderline Personality Disorder and Alcohol Use Disorder (NCT00145678) | State University of New York - Upstate Medical University | 2004-06-01 |
| Verkes Borderline Study: The Effect of Quetiapine on Borderline Personality Disordered Patients (NCT00254748) | AstraZeneca | 2004-06-01 |
| Treatment of Suicidal Women With Borderline Personality Disorder (NCT00183651) | University of Washington | 2004-04-01 |
| Ziprasidone in the Treatment of Borderline Personality Disorder (NCT00635921) | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 2004-03-01 |
| Olanzapine in Patients With Borderline Personality Disorder (NCT00091650) | Eli Lilly and Company | 2004-03-01 |
| Efficacy and Safety of Olanzapine in Patients With Borderline Personality Disorder (NCT00088036) | Eli Lilly and Company | 2004-02-01 |
| Effective Measurement of Risperidone Treatment Outcome for Persons With Borderline Personality Disorder (NCT00204347) | University of Alabama at Birmingham | 2003-07-01 |
| Depakote ER in Borderline Personality Disorder (NCT00222482) | University of Minnesota | 2003-03-01 |
| User Satisfaction Survey - Personality Disorder Service (NCT00202202) | Queen's University | 2002-11-01 |
| Hope for the Chronically Suicidal Patient (NCT00154154) | Centre for Addiction and Mental Health | 2002-10-01 |
| Treatment for Borderline Personality Disorder (NCT00055315) | University of Iowa | 2002-07-01 |
| BOSCOT : A Randomised Controlled Trial of Cognitive Behavioural Therapy in Borderline Personality Disorder (NCT00538135) | University of Aberdeen | 2002-02-01 |
| Chrysalis Day Program Body Mass Index Study (NCT00202215) | Queen's University | 2001-10-01 |
| Cognitive Therapy Versus Supportive Therapy in Borderline Personality Disorder (NCT00131781) | Hospices Civils de Lyon | 2001-03-01 |
| Treating Suicidal Behavior and Self-Mutilation in People With Borderline Personality Disorder (NCT00533117) | New York State Psychiatric Institute | 2001-03-01 |
| Naltrexone in the Treatment of Dissociative Symptoms in Patients With Borderline Personality Disorder (NCT01133301) | Central Institute of Mental Health, Mannheim | 1998-08-01 |
| Effects of Comorbid Personality Disorder on the Treatment of Bipolar I Disorder (NCT00178061) | University of Pittsburgh | 1997-08-01 |
| DBT and Escitalopram in Borderline Personality Disorder (NCT00255554) | Bronx VA Medical Center | |
| Promoting Recovery Processes in Women With Borderline Personality Disorder Using a Dynamic Cognitive Intervention (NCT01531634) | Hillel Yaffe Medical Center | |
| Circadian Sleep-wake Cycles and Light Therapy in Borderline Personality Disorder (NCT01311193) | University Hospital, Basel, Switzerland | |
| DBT in Borderline Personality Disorder (NCT00252031) | Bronx VA Medical Center | |
| Outcome of Crisis Intervention for Subjects With Borderline Personality Disorder or Post-Traumatic Stress Disorder (NCT00269139) | Laddis, Andreas, M.D. | |